Clinical Trials Directory

Trials / Completed

CompletedNCT01142648

Sugammadex and Brain Waves

The Effect of Sugammadex of EEG-derived Index Values

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Tampere University Hospital · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

According to our experience, electroencephalogram-based indices of anaesthetic state show elevated numbers after administration of sugammadex (new reversal of neuromuscular blockade). This can be due to altered anaesthetic state, or some kind of artefact. In this study, the phenomenon is evaluated in detail.

Detailed description

Rocuronium-induced neuromuscular blockade is antagonized with sugammadex or neostigmine. BIS, Entropy and the biosignal collected from the Entropy strip are collected on computer. The behaviour of these parameters before, during and after reversal on neuromuscular blockade will be analyzed in detail.

Conditions

Interventions

TypeNameDescription
DRUGSugammadexSugammadex 200 mg iv, single dose, bolus.
DRUGNeostigmine and glycopyrrolateNeostigmine 2.5 mg and glycopyrrolate 0,5 mg, iv, single dose, bolus, diluted in 2 ml volume with saline

Timeline

Start date
2009-04-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2010-06-11
Last updated
2010-06-11

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01142648. Inclusion in this directory is not an endorsement.